Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5. This indicates a small, internal update to the page build without changing the study content.SummaryDifference0.0%

- Check17 days agoChange DetectedResults for the SatraGO-1 trial have been posted, and the study record now includes extensive outcome data such as Week 24/48 changes in proptosis, diplopia, CAS, GO-QoL, and safety events. The update also lists the associated documentation and timepoints for result reporting.SummaryDifference5%

- Check24 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor site/software update.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study's results status changed from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted for the study and will be posted.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision tag was updated to v3.6.3, indicating a new version of the page content. The previous revision tag v3.6.2 was removed.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.2 is shown, replacing the prior v3.6.0. This reflects a minor update to the page build and does not alter the study content or its presentation.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.